Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Martin Antonio is active.

Publication


Featured researches published by Martin Antonio.


The Lancet | 2013

Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study

Karen L. Kotloff; James P. Nataro; William C. Blackwelder; Dilruba Nasrin; Tamer H. Farag; Sandra Panchalingam; Yukun Wu; Samba O. Sow; Dipika Sur; Robert F. Breiman; Abu S. G. Faruque; Anita K. M. Zaidi; Debasish Saha; Pedro L. Alonso; Boubou Tamboura; Doh Sanogo; Uma Onwuchekwa; Byomkesh Manna; Thandavarayan Ramamurthy; Suman Kanungo; John B. Ochieng; Richard Omore; Joseph Oundo; Anowar Hossain; Sumon Kumar Das; Shahnawaz Ahmed; Shahida Qureshi; Farheen Quadri; Richard A. Adegbola; Martin Antonio

BACKGROUND Diarrhoeal diseases cause illness and death among children younger than 5 years in low-income countries. We designed the Global Enteric Multicenter Study (GEMS) to identify the aetiology and population-based burden of paediatric diarrhoeal disease in sub-Saharan Africa and south Asia. METHODS The GEMS is a 3-year, prospective, age-stratified, matched case-control study of moderate-to-severe diarrhoea in children aged 0-59 months residing in censused populations at four sites in Africa and three in Asia. We recruited children with moderate-to-severe diarrhoea seeking care at health centres along with one to three randomly selected matched community control children without diarrhoea. From patients with moderate-to-severe diarrhoea and controls, we obtained clinical and epidemiological data, anthropometric measurements, and a faecal sample to identify enteropathogens at enrolment; one follow-up home visit was made about 60 days later to ascertain vital status, clinical outcome, and interval growth. FINDINGS We enrolled 9439 children with moderate-to-severe diarrhoea and 13,129 control children without diarrhoea. By analysing adjusted population attributable fractions, most attributable cases of moderate-to-severe diarrhoea were due to four pathogens: rotavirus, Cryptosporidium, enterotoxigenic Escherichia coli producing heat-stable toxin (ST-ETEC; with or without co-expression of heat-labile enterotoxin), and Shigella. Other pathogens were important in selected sites (eg, Aeromonas, Vibrio cholerae O1, Campylobacter jejuni). Odds of dying during follow-up were 8·5-fold higher in patients with moderate-to-severe diarrhoea than in controls (odd ratio 8·5, 95% CI 5·8-12·5, p<0·0001); most deaths (167 [87·9%]) occurred during the first 2 years of life. Pathogens associated with increased risk of case death were ST-ETEC (hazard ratio [HR] 1·9; 0·99-3·5) and typical enteropathogenic E coli (HR 2·6; 1·6-4·1) in infants aged 0-11 months, and Cryptosporidium (HR 2·3; 1·3-4·3) in toddlers aged 12-23 months. INTERPRETATION Interventions targeting five pathogens (rotavirus, Shigella, ST-ETEC, Cryptosporidium, typical enteropathogenic E coli) can substantially reduce the burden of moderate-to-severe diarrhoea. New methods and accelerated implementation of existing interventions (rotavirus vaccine and zinc) are needed to prevent disease and improve outcomes. FUNDING The Bill & Melinda Gates Foundation.


The Journal of Infectious Diseases | 2008

Progression to Active Tuberculosis, but Not Transmission, Varies by Mycobacterium tuberculosis Lineage in The Gambia

Bouke C. de Jong; Philip C. Hill; Alexander M. Aiken; Timothy Awine; Martin Antonio; Ifedayo Adetifa; Dolly Jackson-Sillah; Annette Fox; Kathryn DeRiemer; Sebastien Gagneux; Martien W. Borgdorff; Keith P. W. J. McAdam; Tumani Corrah; Peter M. Small; Richard A. Adegbola

BACKGROUND There is considerable variability in the outcome of Mycobacterium tuberculosis infection. We hypothesized that Mycobacterium africanum was less likely than M. tuberculosis to transmit and progress to tuberculosis disease. METHODS In a cohort study of patients with tuberculosis and their household contacts in The Gambia, we categorized 1808 HIV-negative tuberculosis contacts according to exposure to M. tuberculosis or M. africanum. Positive skin test results indicated transmission, and development of tuberculosis during 2 years of follow-up indicated progression to disease. RESULTS Transmission rates were similar, but rates of progression to disease were significantly lower in contacts exposed to M. africanum than in those exposed to M. tuberculosis (1.0% vs. 2.9%; hazard ratio [HR], 3.1 [95% confidence interval {CI}, 1.1-8.7]). Within M. tuberculosis sensu stricto, contacts exposed to a Beijing family strain were most likely to progress to disease (5.6%; HR relative to M. africanum, 6.7 [95% CI, 2.0-22]). CONCLUSIONS M. africanum and M. tuberculosis transmit equally well to household contacts, but contacts exposed to M. africanum are less likely to progress to tuberculosis disease than those exposed to M. tuberculosis. The variable rate of progression by lineage suggests that tuberculosis variability matters in clinical settings and should be accounted for in studies evaluating tuberculosis vaccines and treatment regimens for latent tuberculosis infection.


The Lancet | 2016

Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study

Jie Liu; James A. Platts-Mills; Jane Juma; Furqan Kabir; Joseph Nkeze; Catherine Okoi; Darwin J. Operario; Jashim Uddin; Shahnawaz Ahmed; Pedro L. Alonso; Martin Antonio; Stephen M. Becker; William C. Blackwelder; Robert F. Breiman; Abu S. G. Faruque; Barry S. Fields; Jean Gratz; Rashidul Haque; Anowar Hossain; M. Jahangir Hossain; Sheikh Jarju; Farah Naz Qamar; Najeeha Talat Iqbal; Brenda Kwambana; Inacio Mandomando; Timothy L. McMurry; Caroline Ochieng; John B. Ochieng; Melvin Ochieng; Clayton O. Onyango

BACKGROUND Diarrhoea is the second leading cause of mortality in children worldwide, but establishing the cause can be complicated by diverse diagnostic approaches and varying test characteristics. We used quantitative molecular diagnostic methods to reassess causes of diarrhoea in the Global Enteric Multicenter Study (GEMS). METHODS GEMS was a study of moderate to severe diarrhoea in children younger than 5 years in Africa and Asia. We used quantitative real-time PCR (qPCR) to test for 32 enteropathogens in stool samples from cases and matched asymptomatic controls from GEMS, and compared pathogen-specific attributable incidences with those found with the original GEMS microbiological methods, including culture, EIA, and reverse-transcriptase PCR. We calculated revised pathogen-specific burdens of disease and assessed causes in individual children. FINDINGS We analysed 5304 sample pairs. For most pathogens, incidence was greater with qPCR than with the original methods, particularly for adenovirus 40/41 (around five times), Shigella spp or enteroinvasive Escherichia coli (EIEC) and Campylobactor jejuni o C coli (around two times), and heat-stable enterotoxin-producing E coli ([ST-ETEC] around 1·5 times). The six most attributable pathogens became, in descending order, Shigella spp, rotavirus, adenovirus 40/41, ST-ETEC, Cryptosporidium spp, and Campylobacter spp. Pathogen-attributable diarrhoeal burden was 89·3% (95% CI 83·2-96·0) at the population level, compared with 51·5% (48·0-55·0) in the original GEMS analysis. The top six pathogens accounted for 77·8% (74·6-80·9) of all attributable diarrhoea. With use of model-derived quantitative cutoffs to assess individual diarrhoeal cases, 2254 (42·5%) of 5304 cases had one diarrhoea-associated pathogen detected and 2063 (38·9%) had two or more, with Shigella spp and rotavirus being the pathogens most strongly associated with diarrhoea in children with mixed infections. INTERPRETATION A quantitative molecular diagnostic approach improved population-level and case-level characterisation of the causes of diarrhoea and indicated a high burden of disease associated with six pathogens, for which targeted treatment should be prioritised. FUNDING Bill & Melinda Gates Foundation.


PLOS Neglected Tropical Diseases | 2010

Mycobacterium africanum—Review of an Important Cause of Human Tuberculosis in West Africa

Bouke C. de Jong; Martin Antonio; Sebastien Gagneux

Mycobacterium africanum consists of two phylogenetically distinct lineages within the Mycobacterium tuberculosis complex, known as M. africanum West African 1 and M. africanum West African 2. These lineages are restricted to West Africa, where they cause up to half of human pulmonary tuberculosis. In this review we discuss the definition of M. africanum, describe the prevalence and restricted geographical distribution of M. africanum West African 1 and 2, review the occurrence of M. africanum in animals, and summarize the phenotypic differences described thus far between M. africanum and M. tuberculosis sensu stricto.


Vaccine | 2013

Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: Updated recommendations from the World Health Organization Pneumococcal Carriage Working Group

Catherine Satzke; Paul Turner; Virolainen-Julkunen A; Peter V. Adrian; Martin Antonio; Kim M. Hare; Ana Maria Henao-Restrepo; Amanda J. Leach; Keith P. Klugman; Barbara D. Porter; Raquel Sá-Leão; Scott Ja; Hanna M. Nohynek; Katherine L. O'Brien

In 2003 the World Health Organization (WHO) convened a working group and published a set of standard methods for studies measuring nasopharyngeal carriage of Streptococcus pneumoniae (the pneumococcus). The working group recently reconvened under the auspices of the WHO and updated the consensus standard methods. These methods describe the collection, transport and storage of nasopharyngeal samples, as well as provide recommendations for the identification and serotyping of pneumococci using culture and non-culture based approaches. We outline the consensus position of the working group, the evidence supporting this position, areas worthy of future research, and the epidemiological role of carriage studies. Adherence to these methods will reduce variability in the conduct of pneumococcal carriage studies undertaken in the context of pneumococcal vaccine trials, implementation studies, and epidemiology studies more generally so variability in methodology does not confound the interpretation of study findings.


Lancet Infectious Diseases | 2014

Development and assessment of molecular diagnostic tests for 15 enteropathogens causing childhood diarrhoea: a multicentre study

Jie Liu; Furqan Kabir; Jainaba Manneh; Paphavee Lertsethtakarn; Sharmin Begum; Jean Gratz; Steve M Becker; Darwin J. Operario; Mami Taniuchi; Lalitha Janaki; James A. Platts-Mills; Doris M. Haverstick; Mamun Kabir; Shihab U. Sobuz; Kaewkanya Nakjarung; Pimmada Sakpaisal; Sasikorn Silapong; Ladaporn Bodhidatta; Shahida Qureshi; Adil Kalam; Queen Saidi; Ndealilia Swai; Buliga Mujaga; Athanasia Maro; Brenda Kwambana; Michel M. Dione; Martin Antonio; Gibson Kibiki; Carl J. Mason; Rashidul Haque

BACKGROUND Childhood diarrhoea can be caused by many pathogens that are difficult to assay in the laboratory. Molecular diagnostic techniques provide a uniform method to detect and quantify candidate enteropathogens. We aimed to develop and assess molecular tests for identification of enteropathogens and their association with disease. METHODS We developed and assessed molecular diagnostic tests for 15 enteropathogens across three platforms-PCR-Luminex, multiplex real-time PCR, and TaqMan array card-at five laboratories worldwide. We judged the analytical and clinical performance of these molecular techniques against comparator methods (bacterial culture, ELISA, and PCR) using 867 diarrhoeal and 619 non-diarrhoeal stool specimens. We also measured molecular quantities of pathogens to predict the association with diarrhoea, by univariate logistic regression analysis. FINDINGS The molecular tests showed very good analytical and clinical performance at all five laboratories. Comparator methods had limited sensitivity compared with the molecular techniques (20-85% depending on the target) but good specificity (median 97·3%, IQR 96·5-98·9; mean 95·2%, SD 9·1). Positive samples by comparator methods usually had higher molecular quantities of pathogens than did negative samples, across almost all platforms and for most pathogens (p<0·05). The odds ratio for diarrhoea at a given quantity (measured by quantification cycle, Cq) showed that for most pathogens associated with diarrhoea-including Campylobacter jejuni and Campylobacter coli, Cryptosporidium spp, enteropathogenic Escherichia coli, heat-stable enterotoxigenic E coli, rotavirus, Shigella spp and enteroinvasive E coli, and Vibrio cholerae-the strength of association with diarrhoea increased at higher pathogen loads. For example, Shigella spp at a Cq range of 15-20 had an odds ratio of 8·0 (p<0·0001), but at a Cq range of 25-30 the odds ratio fell to 1·7 (p=0·043). INTERPRETATION Molecular diagnostic tests can be implemented successfully and with fidelity across laboratories around the world. In the case of diarrhoea, these techniques can detect pathogens with high sensitivity and ascribe diarrhoeal associations based on quantification, including in mixed infections, providing rich and unprecedented measurements of infectious causes. FUNDING Bill & Melinda Gates Foundation Next Generation Molecular Diagnostics Project.


Genome Biology | 2014

Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition

Mihai Pop; Alan W. Walker; Joseph N. Paulson; Brianna Lindsay; Martin Antonio; M. Anowar Hossain; Joseph Oundo; Boubou Tamboura; Volker Mai; Irina Astrovskaya; Héctor Corrada Bravo; Richard Rance; Mark D. Stares; Myron M. Levine; Sandra Panchalingam; Karen Kotloff; Usman N. Ikumapayi; Chinelo Ebruke; Mitchell Adeyemi; Dilruba Ahmed; Firoz Ahmed; Meer T. Alam; Ruhul Amin; Sabbir Siddiqui; John B. Ochieng; Emmanuel Ouma; Jane Juma; Euince Mailu; Richard Omore; J. Glenn Morris

BackgroundDiarrheal diseases continue to contribute significantly to morbidity and mortality in infants and young children in developing countries. There is an urgent need to better understand the contributions of novel, potentially uncultured, diarrheal pathogens to severe diarrheal disease, as well as distortions in normal gut microbiota composition that might facilitate severe disease.ResultsWe use high throughput 16S rRNA gene sequencing to compare fecal microbiota composition in children under five years of age who have been diagnosed with moderate to severe diarrhea (MSD) with the microbiota from diarrhea-free controls. Our study includes 992 children from four low-income countries in West and East Africa, and Southeast Asia. Known pathogens, as well as bacteria currently not considered as important diarrhea-causing pathogens, are positively associated with MSD, and these include Escherichia/Shigella, and Granulicatella species, and Streptococcus mitis/pneumoniae groups. In both cases and controls, there tend to be distinct negative correlations between facultative anaerobic lineages and obligate anaerobic lineages. Overall genus-level microbiota composition exhibit a shift in controls from low to high levels of Prevotella and in MSD cases from high to low levels of Escherichia/Shigella in younger versus older children; however, there was significant variation among many genera by both site and age.ConclusionsOur findings expand the current understanding of microbiota-associated diarrhea pathogenicity in young children from developing countries. Our findings are necessarily based on correlative analyses and must be further validated through epidemiological and molecular techniques.


Virology | 2013

Discovery of STL polyomavirus, a polyomavirus of ancestral recombinant origin that encodes a unique T antigen by alternative splicing

Efrem S. Lim; Alejandro Reyes; Martin Antonio; Debasish Saha; Usman N. Ikumapayi; Mitchell Adeyemi; O. Colin Stine; Rebecca Skelton; Daniel C. Brennan; Rajhab S. Mkakosya; Mark J. Manary; Jeffrey I. Gordon; David Wang

The family Polyomaviridae is comprised of circular double-stranded DNA viruses, several of which are associated with diseases, including cancer, in immunocompromised patients. Here we describe a novel polyomavirus recovered from the fecal microbiota of a child in Malawi, provisionally named STL polyomavirus (STLPyV). We detected STLPyV in clinical stool specimens from USA and The Gambia at up to 1% frequency. Complete genome comparisons of two STLPyV strains demonstrated 5.2% nucleotide divergence. Alternative splicing of the STLPyV early region yielded a unique form of T antigen, which we named 229T, in addition to the expected large and small T antigens. STLPyV has a mosaic genome and shares an ancestral recombinant origin with MWPyV. The discovery of STLPyV highlights a novel alternative splicing strategy and advances our understanding of the complex evolutionary history of polyomaviruses.


Clinical Infectious Diseases | 2014

Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development

Sofie Livio; Nancy A. Strockbine; Sandra Panchalingam; Sharon M. Tennant; Eileen M. Barry; Mark E. Marohn; Martin Antonio; Anowar Hossain; Inacio Mandomando; John B. Ochieng; Joseph Oundo; Shahida Qureshi; Thandavarayan Ramamurthy; Boubou Tamboura; Richard A. Adegbola; Mohammed Jahangir Hossain; Debasish Saha; Sunil Sen; Abu Syed Golam Faruque; Pedro L. Alonso; Robert F. Breiman; Anita K. M. Zaidi; Dipika Sur; Samba O. Sow; Lynette Y. Berkeley; Ciara E. O'Reilly; Eric D. Mintz; Kousick Biswas; Dani Cohen; Tamer H. Farag

Shigella case isolates from the Global Enteric Multicenter Study were serotyped to guide vaccine development. A quadrivalent vaccine that includes O antigens from S. sonnei, S. flexneri 2a, S. flexneri 3a, and S. flexneri 6 should provide broad protection.


Clinical Infectious Diseases | 2012

Diagnostic Microbiologic Methods in the GEMS-1 Case/Control Study

Sandra Panchalingam; Martin Antonio; Anowar Hossain; Inacio Mandomando; Ben Ochieng; Joseph Oundo; Thandavarayan Ramamurthy; Boubou Tamboura; Anita K. M. Zaidi; William A. Petri; Eric R. Houpt; Patrick Murray; Valeria Prado; Roberto Vidal; Duncan Steele; Nancy A. Strockbine; Philippe J. Sansonetti; Roger I. Glass; Roy M. Robins-Browne; Marija Tauschek; A. M. Svennerholm; Karen L. Kotloff; Myron M. Levine; James P. Nataro

To understand the etiology of moderate-to-severe diarrhea among children in high mortality areas of sub-Saharan Africa and South Asia, we performed a comprehensive case/control study of children aged <5 years at 7 sites. Each site employed an identical case/control study design and each utilized a uniform comprehensive set of microbiological assays to identify the likely bacterial, viral and protozoal etiologies. The selected assays effected a balanced consideration of cost, robustness and performance, and all assays were performed at the study sites. Identification of bacterial pathogens employed streamlined conventional bacteriologic biochemical and serological algorithms. Diarrheagenic Escherichia coli were identified by application of a multiplex polymerase chain reaction assay for enterotoxigenic, enteroaggregative, and enteropathogenic E. coli. Rotavirus, adenovirus, Entamoeba histolytica, Giardia enterica, and Cryptosporidium species were detected by commercially available enzyme immunoassays on stool samples. Samples positive for adenovirus were further evaluated for adenovirus serotypes 40 and 41. We developed a novel multiplex assay to detect norovirus (types 1 and 2), astrovirus, and sapovirus. The portfolio of diagnostic assays used in the GEMS study can be broadly applied in developing countries seeking robust cost-effective methods for enteric pathogen detection.

Collaboration


Dive into the Martin Antonio's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bouke C. de Jong

Institute of Tropical Medicine Antwerp

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jacob Otu

Medical Research Council

View shared research outputs
Top Co-Authors

Avatar

Tumani Corrah

Medical Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michel M. Dione

International Livestock Research Institute

View shared research outputs
Top Co-Authors

Avatar

Debasish Saha

Medical Research Council

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge